Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Bladder Cancer

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 13 articles: HTML format

Single Articles

November 2024
1. ALEMAN A, Adrien L, Lopez-Serra L, Cordon-Cardo C, et al
   Editorial Expression of Concern: Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.
   Br J Cancer. 2024 Nov 18. doi: 10.1038/s41416-024-02903.
   PubMed    
   
   
   October 2024
2. LU JL, Ye YL, Zheng DD, Shi XY, et al
   Temporal dynamics of immune cell patterns in bladder cancer patients receiving Bacillus Calmette-Guerin therapy.
   Br J Cancer. 2024 Oct 31. doi: 10.1038/s41416-024-02883.
   PubMed     Abstract available
   
   
   April 2024
3. JONES RJ, Crabb SJ, Linch M, Birtle AJ, et al
   Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective.
   Br J Cancer. 2024;130:897-907.
   PubMed     Abstract available
   
   
   March 2024
4. OUYANG Y, Zhong W, Xu P, Wang B, et al
   Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial bladder carcinoma through the COX-2/PGE2/IDO1 Axis.
   Br J Cancer. 2024;130:880-891.
   PubMed     Abstract available
   
   
   February 2024
5. ZHANG L, Zhang R, Jin D, Zhang T, et al
   Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer.
   Br J Cancer. 2024 Feb 8. doi: 10.1038/s41416-024-02598.
   PubMed     Abstract available
   
   
   
6. FONT A, Mellado B, Climent MA, Virizuela JA, et al
   Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
   Br J Cancer. 2024;130:434-441.
   PubMed     Abstract available
   
   
   January 2024
7. SU X, Jin K, Guo Q, Xu Z, et al
   Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer.
   Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02572.
   PubMed     Abstract available
   
   
   December 2023
8. VIERGEVER BJ, Raats DAE, Geurts V, Mullenders J, et al
   Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.
   Br J Cancer. 2023 Dec 15. doi: 10.1038/s41416-023-02494.
   PubMed     Abstract available
   
   
   September 2023
9. LIM EH, Franklin P, Trevenen ML, Nieuwenhuijsen M, et al
   Exposure to low-level ambient air pollution and the relationship with lung and bladder cancer in older men, in Perth, Western Australia.
   Br J Cancer. 2023 Sep 8. doi: 10.1038/s41416-023-02411.
   PubMed     Abstract available
   
   
   August 2023
10. LU J, Lai J, Xiao K, Peng S, et al
    A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study.
    Br J Cancer. 2023 Aug 4. doi: 10.1038/s41416-023-02383.
    PubMed     Abstract available
    
    
    July 2023
11. SHALA NK, Stenehjem JS, Babigumira R, Liu FC, et al
    Exposure to benzene and other hydrocarbons and risk of bladder cancer among male offshore petroleum workers.
    Br J Cancer. 2023 Jul 18. doi: 10.1038/s41416-023-02357.
    PubMed     Abstract available
    
    
    June 2023
12. YAMAMOTO S, Kato M, Takeyama Y, Azuma Y, et al
    Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.
    Br J Cancer. 2023;128:2197-2205.
    PubMed     Abstract available
    
    
    March 2023
13. VASDEV N
    Multicentric validation of nomograms based on BC-116 and BC-106 urine peptide biomarker panels for bladder cancer diagnostics and monitoring in two prospective cohorts of patients.
    Br J Cancer. 2023 Mar 1. doi: 10.1038/s41416-023-02142.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.